BUSINESS

December Public Offerings: Biotechs and EV Company Report

PUBLISHED Dec 9, 2025, 6:41 AM ET

Read, Watch or Listen

Media Bias Meter

Sources: 7

Center 100%

Sources: 7

United States. Several companies announced or completed public equity offerings this week. On Dec. 9 Terns Pharmaceuticals filed for a proposed $400 million offering with a 30-day option for $60 million, and Denali Therapeutics filed for a $200 million offering with a $30 million option. On Dec. 11 Blink Charging priced 26,666,666 shares at $0.75 raising about $20 million, Tenaya Therapeutics filed to offer units, and on Dec. 11 Terns and Dyne Therapeutics closed upsized offerings raising roughly $747.5 million and $402.5 million respectively. Underwriters and SEC filings accompanied the announcements. Based on 7 articles reviewed independently and supporting research.

By James Porter | JQJO News

Timeline of Events

Dec. 9, 2025 — Terns announces proposed $400M offering and $60M option.
Dec. 9, 2025 — Denali Therapeutics announces proposed $200M offering and $30M option.
Dec. 10, 2025 — SEC declares Blink Charging registration effective (Form S-1).
Dec. 11, 2025 — Blink prices 26,666,666 shares at $0.75 per share.
Dec. 11, 2025 — Terns and Dyne close offerings, reporting $747.5M and $402.5M gross proceeds.

Media Bias

Articles Published:: 7
Right Leaning:: 0
Left Leaning:: 0
Neutral:: 7

Who Benefited

Companies including Terns, Dyne, Denali, Blink Charging and Tenaya benefited by raising capital to finance research, clinical trials, manufacturing, working capital and EV network expansion, extending operational runway and enabling near-term program and infrastructure activities.

Who Impacted

Existing common shareholders experienced potential dilution risk as companies issued common shares, pre-funded warrants and units, increasing outstanding share counts and potentially reducing per-share ownership and future earnings per share.

Media Bias